State court dismisses Mississippi’s pay-for-delay claims against Teva

The State of Mississippi has failed to demonstrate that a state court has jurisdiction over claims that Teva Pharmaceuticals entered into an anticompetitive reverse-payment settlement, a local judge has ruled.

Unlock unlimited access to all Global Competition Review content